Comparison of the Effect of Cervical Mucus Cleaning Method Applied Before Embryo Transfer on Pregnancy Rates.

The Effect of Two Different Cervical Mucus Removal Methods on Pregnancy Rates. 180 Cases Will be Randomized Into 3 Groups for Cervical Mucus Intervention. Removal With Cotton Swab, Removal With Cannula and Mucus Left on Cervix.

To assess the impact of cervical mucus cleansing before embryo transfer and compare two different instruments for this purpose.

Study Overview

Status

Completed

Conditions

Detailed Description

All patients will be informed about the study and those who give written consent will be included in the study.

Women undergoing good quality embryo transfer will be assigned to one of the 3 arms of the study according to the previously determined randomization chart. The first evaluation of the patient will be made on the 12th day after embryo transfer. Pregnancy status will be evaluated with serum βhcg value. If pregnancy is confirmed by serum βhcg value, fetal viability will be evaluated by ultrasound 4 weeks after transfer.

Study Type

Interventional

Enrollment (Actual)

183

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34668
        • Zeynep Kamil Women and Children's Diseases Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 21-40 years old women,
  • Women undergoing good quality embryo transfer,
  • Women who are eligible for a single or double embryo transfer.

Exclusion Criteria:

  • If there is a diagnosis of a uterine anomaly,
  • If there is a diagnosis of myoma uteri,
  • If there is a diagnosis of rheumatological disease,
  • Women to be transferred other than good quality embryo,
  • Hİstory of previous pelvic, gynecological operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Cervical mucus removal with cotton swab
Cervical mucus will be removed with cotton swab before embryo transfer
Removal of the cervical mucus with a cotton swab before embryo transfer.
Active Comparator: Cervical mucus removal with cannula
Cervical mucus will be removed with cannula before embryo transfer
Removal of the cervical mucus with a cannula before embryo transfer.
No Intervention: No cervical mucus removal
Cervical mucus will not be removed prior to embryo transfer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detecting pregnancy after embryo transfer.
Time Frame: 12 days after embryo transfer/ intervention.
Confirmation of pregnancy with serum βhcg value at the earliest 12th day after embryo transfer.
12 days after embryo transfer/ intervention.
Confirmation of fetal cardiac activity in detected pregnancy.
Time Frame: 3-4 weeks after embryo transfer/ intervention.
Evaluation of fetal cardiac activity on ultrasound.
3-4 weeks after embryo transfer/ intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of embryo transfer during intervention.
Time Frame: 5 minutes after embryo transfer.
In some cases, the embryo is transferred to the endometrial cavity and comes back with the transfer cannula. For this reason, the embryology laboratory checks the transfer cannula after the transfer. If the embryo is still in the embryo transfer cannula, a second attempt is made for embryo transfer. As a secondary outcome, we will evaluate the success in the first attempt for embryo transfer.
5 minutes after embryo transfer.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Belgin Devranoğlu, Ass. Prof., Zeynep Kamil Women and Children's Diseases Training and Research Hospital
  • Study Director: Müşerref Banu Yılmaz, Md., Zeynep Kamil Women and Children's Diseases Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 25, 2021

Primary Completion (Actual)

July 8, 2022

Study Completion (Actual)

July 8, 2022

Study Registration Dates

First Submitted

May 3, 2021

First Submitted That Met QC Criteria

May 10, 2021

First Posted (Actual)

May 17, 2021

Study Record Updates

Last Update Posted (Estimated)

February 23, 2024

Last Update Submitted That Met QC Criteria

February 22, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 90-07.April.2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Cotton swab

Subscribe